Cleveland Clinic Study Will Measure NSAID Safety In Heart Disease Patients
This article was originally published in The Pink Sheet Daily
Executive Summary
The 20,000-patient study comparing ibuprofen, naproxen and celecoxib will be funded by Pfizer but completely overseen by the clinic.